Human neutralizing monoclonal antibodies are candidates for prophylactic and therapeutic interventions against Middle East respiratory syndrome coronavirus (MERS-CoV) infection.
year โฐ 2014
issn ๐Ÿ—„ 19466242 19466234
volume 6
number 235
page
citedbycount 4